The Bronx, NY Clinical Trials Report — April 2026

For residents of The Bronx considering participation in clinical research, April 2026 presents a critical window for those looking to join studies before enrollment closes. A total of 46 clinical trials in The Bronx are slated to conclude within the next 90 days. This urgency is particularly relevant for healthy volunteers, as 6 of these rapidly closing studies are still actively seeking participants without specific health conditions. Individuals interested in contributing to medical advancements should explore these options promptly.

Upcoming Deadlines for Diverse Conditions

Patients managing certain health conditions also face impending deadlines to join research. Trials focused on various cancers, cardiovascular health, and mental health are among those with limited time remaining for enrollment. Conditions with trials closing soon include:

• Metastatic malignant solid neoplasm (2 trials)
• Stage IV lung cancer AJCC V8 (2 trials)
• Breast cancer (2 trials)
• Advanced NSCLC (1 trial)
• Coronary artery calcification (1 trial)
• Cervical carcinoma (1 trial)
• Atrial fibrillation (1 trial)
• Colon cancer (1 trial)
• Comorbid post-traumatic stress disorder and OCD (1 trial)
• Contraception (1 trial)

This month, The Bronx saw the opening of 6 new clinical trials, an increase from the 5 trials that launched in March 2026. This brings the total number of actively recruiting trials in The Bronx to 556, spread across 193 research facilities.

Spotlight on New Research Opportunities

April brings several notable new trials to The Bronx, including significant Phase 2 and Phase 3 studies from major sponsors. These trials offer participants the chance to engage with cutting-edge treatments and diagnostic approaches across a range of health challenges.

• Incyte Corporation is launching NCT07522073, "A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma." This important Phase 3 oncology trial seeks 588 participants to evaluate the efficacy and safety of a new combination therapy for solid tumors.
• Eli Lilly and Company is initiating NCT07533019, "A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo." This Phase 2 study, designed for 60 participants, will evaluate how well LY4005130 is tolerated and what side effects may occur in participants with non-segmental vitiligo (NSV) when compared with placebo.
• Montefiore Medical Center is sponsoring NCT07548372, "SPARK-CGM Implementation." This study aims to enroll 20,000 participants to improve the implementation of Continuous Glucose Monitoring (CGM) technology for individuals with diabetes mellitus, helping them better manage their sugar levels.
• A study led by Xu Liu, NCT07541989, "Pulsed-Field Ablation With/Without Electrogram Mapping," is investigating optimal strategies for pulsed field ablation (PFA) in treating non-paroxysmal atrial fibrillation, with a goal of 300 participants.

New trials this month are exploring a range of conditions, including diabetes mellitus, genitourinary symptoms, HIV, menopausal complaints, menopause related conditions, non-paroxysmal atrial fibrillation, non-segmental vitiligo (NSV), opioid tapering, perimenopause, and solid tumors. Of the 6 new trials, 3 are drug trials, 3 are categorized as 'other' research, and 1 involves a procedure. All 6 new trials include older adults, and 1 is specifically for female participants.

The Bronx's Research Hubs

The Bronx is home to several leading research institutions that consistently run a high volume of clinical trials. These facilities are key destinations for individuals seeking to participate in medical research:

• Montefiore Medical Center (162 trials)
• Montefiore Medical Center - Moses Campus (77 trials)
• Montefiore Medical Center-Einstein Campus (60 trials)
• Montefiore Medical Center-Weiler Hospital (31 trials)
• Research Site (21 trials)
• Albert Einstein College of Medicine (19 trials)
• Children's Hospital at Montefiore (17 trials)
• James J. Peters VA Medical Center, Bronx, NY (14 trials)
• Jacobi Medical Center (13 trials)
• James J Peters VA Medical Center (10 trials)
• Montefiore Einstein Comprehensive Cancer Center (10 trials)
• Adams Clinical Bronx (8 trials)

These institutions, particularly the extensive Montefiore Medical Center network and Albert Einstein College of Medicine, offer a broad spectrum of research, from oncology and diabetes to cardiovascular health and infectious diseases.

Opportunities for Healthy Volunteers

For individuals without a specific medical condition, there are significant opportunities to contribute. As mentioned, 6 closing trials are still seeking healthy volunteers. More broadly, a total of 44 clinical trials are currently recruiting healthy participants in The Bronx, providing numerous avenues for those interested in supporting medical research.

Broadening Your Search: Nearby Options

While The Bronx offers a substantial array of clinical trial opportunities, individuals may also find options in nearby communities within New York State. Cities with active trials include New York (42 trials), Harrison (8 trials), Commack (8 trials), Uniondale (4 trials), Brooklyn (3 trials), Rockville Centre (3 trials), Lake Success (2 trials), and Rochester (2 trials).

As we move further into spring, the focus will remain on the ongoing enrollment in these significant trials and the continued exploration of new therapeutic strategies, with The Bronx's robust research community at the forefront of medical innovation.